Vas Abramov-President & CEO

With 24 years of experience in medical device product development, Vas joined the TETRAS program in the development stage as Lead Engineer. He was tasked with addressing critical challenges faced by modern peptide synthesizers, such as cross-contamination, limited scalability, and downtime inefficiencies. A key focus was solving the inability to synthesize multiple peptides simultaneously—a need unmet by the numerous multiple-peptide synthesizers on the market, none of which operate asynchronously. By combining innovative engineering with practical design, Vas spearheaded the creation of TETRAS, the first asynchronous peptide synthesizer. Unlike traditional systems, TETRAS can run continuously, allowing chemists to add new reactions and remove completed reactors at any time. This breakthrough drastically enhances lab productivity while minimizing costly downtime. By solving these common issues, TETRAS quickly became the preferred choice for peptide chemists across four continents. For over a decade, it has remained at the forefront of peptide science. The rapid success of TETRAS led to the founding of our sister company, Occam Design, which now exclusively builds and services the TETRAS platform. Vas oversees the unified teams of Occam Design and Thuramed, where he has directed the development of over 20 medical devices. His expertise spans engineering, quality control, regulatory compliance, and production operations, ensuring that TETRAS remains a trusted name in peptide synthesis worldwide.